Expression analysis of MDR1, BCRP and MRP3 transporter proteins in different in vitro and ex vivo cornea models for drug absorption studies.

Ocular drug absorption studies are required for the development of new drugs or drug delivery systems for eye treatment. Such preclinical investigations on transcorneal drug absorption are performed ex vivo with the excised corneas of experimental animals or in vitro using corneal cell culture models. The data currently available on the expression of ABC transporter proteins in corneal tissue is limited or contradictory. This study describes, for the first time, the comparison of the expression of ABC transporters, in particular, MDR1, BCRP and MRP3, between human cornea cell culture models and the most commonly used ex vivo models, namely, rabbit and porcine corneas, conducted in the same laboratory. The expression levels and functionality were determined by means of PCR, western blot, immunohistochemistry and bidirectional permeation studies using specific substrates and inhibitors. The results clearly indicate species-dependent expression of the studied efflux transporters. In the rabbit cornea, the expression and activity of MDR1 transporter was confirmed, whereas human cell culture models and porcine corneas did not show MDR1 expression. However, human cornea models possessed MRP3 and BCRP expression, whereas no functional expression was found in rabbit and porcine corneas. Therefore, the translation of transcorneal permeation data from animal experiments to humans should be performed with caution.

[1]  Stephan Reichl,et al.  In vitro cell culture models to study the corneal drug absorption , 2011, Expert opinion on drug metabolism & toxicology.

[2]  E. Y. Zhang,et al.  Characterization of Human Corneal Epithelial Cell Model As a Surrogate for Corneal Permeability Assessment: Metabolism and Transport , 2009, Drug Metabolism and Disposition.

[3]  A. Mitra,et al.  Modulation of P-glycoprotein-mediated efflux by prodrug derivatization: an approach involving peptide transporter-mediated influx across rabbit cornea. , 2006, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.

[4]  A. Mitra,et al.  Molecular Expression and Functional Evidence of a Drug Efflux Pump (BCRP) in Human Corneal Epithelial Cells , 2009, Current eye research.

[5]  A. Urtti,et al.  Culture model of human corneal epithelium for prediction of ocular drug absorption. , 2001, Investigative ophthalmology & visual science.

[6]  A. Urtti,et al.  Ocular Pharmacokinetic Modeling Using Corneal Absorption and Desorption Rates from in Vitro Permeation Experiments with Cultured Corneal Epithelial Cells , 2003, Pharmaceutical Research.

[7]  Tao Zhang,et al.  Drug Transporter and Cytochrome P450 mRNA Expression in Human Ocular Barriers: Implications for Ocular Drug Disposition , 2008, Drug Metabolism and Disposition.

[8]  C. Xia,et al.  EXPRESSION, LOCALIZATION, AND FUNCTIONAL CHARACTERISTICS OF BREAST CANCER RESISTANCE PROTEIN IN CACO-2 CELLS , 2005, Drug Metabolism and Disposition.

[9]  A. I. Schneider,et al.  The use of an in vitro cornea for predicting ocular toxicity , 1997 .

[10]  K. Hayashi,et al.  An SV 40-Immortalized Human Corneal Epithelial Cell Line and Its Characterization , 2005 .

[11]  Olivier Fardel,et al.  Analysis of drug transporter expression in human intestinal Caco‐2 cells by real‐time PCR , 2007, Fundamental & clinical pharmacology.

[12]  H. Sasaki,et al.  Delivery of drugs to the eye by topical application , 1996, Progress in Retinal and Eye Research.

[13]  H. Sugihara,et al.  Reconstruction of cornea in three-dimensional collagen gel matrix culture. , 1993, Investigative ophthalmology & visual science.

[14]  Shufeng Zhou,et al.  Multidrug resistance associated proteins as determining factors of pharmacokinetics and pharmacodynamics of drugs. , 2007, Current drug metabolism.

[15]  A Rzhetsky,et al.  The human ATP-binding cassette (ABC) transporter superfamily. , 2001, Journal of lipid research.

[16]  D. Monti,et al.  Development of cultured rabbit corneal epithelium for drug permeation studies: a comparison with excised rabbit cornea. , 2004, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.

[17]  C. Müller-Goymann,et al.  [Development of an organotypic corneal construction as an in vitro model for permeability studies]. , 2001, Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft.

[18]  M. Häkli,et al.  Effluxing ABC transporters in human corneal epithelium. , 2010, Journal of pharmaceutical sciences.

[19]  M. Prausnitz,et al.  Permeability of cornea, sclera, and conjunctiva: a literature analysis for drug delivery to the eye. , 1998, Journal of pharmaceutical sciences.

[20]  U. K. Laemmli,et al.  Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.

[21]  I. Papantoniou,et al.  Reconstruction of an in vitro cornea and its use for drug permeation studies from different formulations containing pilocarpine hydrochloride. , 2001, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[22]  J. Forrester,et al.  The suprabasal layer of corneal epithelial cells represents the major barrier site to the passive movement of small molecules and trafficking leukocytes , 2006, British Journal of Ophthalmology.

[23]  Sujit K. Basu,et al.  Air-Interface Condition Promotes the Formation of Tight Corneal Epithelial Cell Layers for Drug Transport Studies , 2000, Pharmaceutical Research.

[24]  A. Murakami,et al.  Expression and Distribution of Junctional Adhesion Molecule-1 in the Human Cornea , 2007, Japanese Journal of Ophthalmology.

[25]  T. Murakami,et al.  Intestinal efflux transporters and drug absorption. , 2008, Expert opinion on drug metabolism & toxicology.

[26]  Stephan Reichl,et al.  Development of a serum-free human cornea construct for in vitro drug absorption studies: the influence of varying cultivation parameters on barrier characteristics. , 2010, International journal of pharmaceutics.

[27]  M. Engelke,et al.  A Human Corneal Equivalent Constructed from SV40-immortalised Corneal Cell Lines , 2005, Alternatives to laboratory animals : ATLA.

[28]  H. Handa,et al.  An SV40-immortalized human corneal epithelial cell line and its characterization. , 1995, Investigative ophthalmology & visual science.

[29]  V. Ganapathy,et al.  Molecular evidence and functional expression of P-glycoprotein (MDR1) in human and rabbit cornea and corneal epithelial cell lines. , 2003, Investigative ophthalmology & visual science.

[30]  D. Greco,et al.  Gene expression analysis in SV-40 immortalized human corneal epithelial cells cultured with an air-liquid interface , 2010, Molecular vision.

[31]  J. Fogh,et al.  New Human Tumor Cell Lines , 1975 .

[32]  S Reichl,et al.  Human corneal equivalent as cell culture model for in vitro drug permeation studies , 2004, British Journal of Ophthalmology.

[33]  Kazuhito Yamada,et al.  Characterization of cyclosporin A transport in cultured rabbit corneal epithelial cells: P-glycoprotein transport activity and binding to cyclophilin. , 1999, Investigative ophthalmology & visual science.

[34]  Kati-Sisko Vellonen,et al.  Drug transport in corneal epithelium and blood-retina barrier: emerging role of transporters in ocular pharmacokinetics. , 2006, Advanced drug delivery reviews.

[35]  H. Sasaki,et al.  Transport of acebutolol through rabbit corneal epithelium. , 2006, Biological & pharmaceutical bulletin.

[36]  M. Khan,et al.  Permeability of Chemical Delivery Systems Across Rabbit Corneal (SIRC) Cell Line and Isolated Corneas: A Comparative Study , 2000, Pharmaceutical development and technology.

[37]  Tomi Järvinen,et al.  Ocular absorption following topical delivery , 1995 .

[38]  S Reichl,et al.  Cultivation and characterization of a bovine in vitro model of the cornea. , 2004, Die Pharmazie.

[39]  M. M. Bradford A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.

[40]  M. Braun,et al.  Establishing and functional testing of a canine corneal construct. , 2008, Veterinary ophthalmology.

[41]  Stephan Reichl,et al.  Prevalidation of a human cornea construct as an alternative to animal corneas for in vitro drug absorption studies. , 2012, Journal of pharmaceutical sciences.

[42]  Y. Kawashima,et al.  Beta adrenergic antagonist permeation across cultured rabbit corneal epithelial cells grown on permeable supports. , 1998, Current eye research.

[43]  C. Ehrhardt,et al.  A Comparative Evaluation of Corneal Epithelial Cell Cultures for Assessing Ocular Permeability , 2008, Alternatives to laboratory animals : ATLA.

[44]  M. Niemi,et al.  Membrane transporters in drug development , 2010, Nature Reviews Drug Discovery.

[45]  Stephan Reichl,et al.  Cell culture models of the human cornea — a comparative evaluation of their usefulness to determine ocular drug absorption in‐vitro , 2008, The Journal of pharmacy and pharmacology.

[46]  Ulf Norinder,et al.  Identification of Novel Specific and General Inhibitors of the Three Major Human ATP-Binding Cassette Transporters P-gp, BCRP and MRP2 Among Registered Drugs , 2009, Pharmaceutical Research.

[47]  G. Szakács,et al.  Human multidrug resistance ABCB and ABCG transporters: participation in a chemoimmunity defense system. , 2006, Physiological reviews.

[48]  C. Müller-Goymann,et al.  [Esterase activity of human organotypic cornea construct (HCC) as in vitro model for permeation studies]. , 2005, Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft.

[49]  Y. Omidi,et al.  Ocular novel drug delivery: impacts of membranes and barriers. , 2008, Expert opinion on drug delivery.

[50]  K. Ruprecht,et al.  Expression of ABC-transporters in human corneal tissue and the transformed cell line, HCE-T. , 2007, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.

[51]  S. Reich,et al.  Entwicklung eines organotypischen Korneakonstruktes als ein In-vitro-Modell für Permeationsstudien , 2001, Der Ophthalmologe.

[52]  E. Toropainen,et al.  Paracellular and passive transcellular permeability in immortalized human corneal epithelial cell culture model. , 2003, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[53]  L. Meyer,et al.  Esteraseaktivität eines organotypischen humanen Kornea-Konstrukts (HCC) als In-vitro-Modell für Permeationsuntersuchungen , 2005, Der Ophthalmologe.

[54]  W. Duan,et al.  Substrates and inhibitors of human multidrug resistance associated proteins and the implications in drug development. , 2008, Current medicinal chemistry.

[55]  M. Griffith,et al.  Functional human corneal equivalents constructed from cell lines. , 1999, Science.

[56]  Y. Omidi,et al.  Ocular novel drug delivery: impacts of membranes and barriers , 2008, Expert opinion on drug delivery.